Shionogi and F2G have reported positive top line data from the global OASIS Phase III study evaluating oral antifungal drug ...
The rate of drug-related treatment-emergent adverse events (TEAEs) was 35.8% for olorofim and 63.9% for AmBisome® followed by standard of care MANCHESTER, United Kingdom and OSAKA, Japan, (GLOBE ...
Scientists rarely expect to find drug resistance in places that are untouched by drugs. The Three Parallel Rivers region of Yunnan, China, sits high in the Eastern Himalayas, far from clinics, farms, ...
Maintenance revumenib was restarted post SCT at the pretransplant dose with azole-based adjustments across monotherapy, combination-trial, and expanded-access settings in genetically defined ...
Azole-6-nitro-[1,5-a]pyrimidine, a promising energetic building block, was rationally designed and efficiently synthesized via an aqueous synthetic route. Employing this versatile precursor, three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results